T4 cells are used as a surrogate marker in people who are HIV-positive. The T4 cell count itself is not really a direct measure of HIV, but a declining count is a sign that disease is progressing. The T4 cell count is then said to be a surrogate marker for HIV. Different surrogate markers are being studied to see how well they measure the progress of HIV.
A surrogate marker is a change to the human body that is known to be a stage in a fatal disease’s development, and would be an indicator of the patient’s demise if left untreated. They provide a way to test the effectiveness of a cure for a fatal disease without waiting for a statistically significant number of deaths to occur. For example, a patient with TTP would be monitored for fragmented blood cells, a surrogate marker for organ failure or stroke.